Maintaining GDMT while lowering potassium in heart failure - PACE-CME

Maintaining GDMT while lowering potassium in heart failure

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
MinuteCE®
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
0.75 program credits
- Gianluigi Savarese, MD
0.75 program credits
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
0.75 program credits
- James Burton, MD
- Aaron Wong, MD
0.75 program credits
MinuteCE®
Bridging the Gap: ns-MRAs in Modern Cardiorenal-Metabolic Care
1.25 credits 4 episodes
- Pardeep Jhund, MD, PhD
- Hiddo L. Heerspink, PhD
- John McMurray, MD
1.25 credits 4 episodes
Nonsteroidal MRAs: The CKD/T2D Advantage
Nonsteroidal MRAs: The CKD/T2D Advantage
MinuteCE®
Nonsteroidal MRAs: The CKD/T2D Advantage
1.25 program credits
- John McMurray, MD
- Pardeep Jhund, MD, PhD
1.25 program credits